You are here
Research Grants (R series)
Research grants make up the largest category of funding and support by the NIDCD. These grants may be awarded to universities, medical and other health professional schools, colleges, hospitals, research institutes, for-profit organizations, and government institutions that sponsor and conduct biomedical research and development. Research grants may provide funds for salaries, equipment, supplies, travel, and other allowable direct costs of the research as well as for indirect costs to the sponsoring institution or organization.
On this page:
- Research Project Grant (R01)
- AREA Grant (R15)
- Exploratory/Developmental Research Grant Award (R21)
- Early Career Research (ECR) Award (R21)
Research Project Grant (R01)
Investigator-initiated Research Project Grants (R01) make up the largest single category of support provided by the NIDCD and by the NIH. The R01 is considered the traditional grant mechanism. These grants are awarded to organizations on behalf of an individual (a principal investigator, or PI) to facilitate pursuit of a research objective in the area of the investigator's research interests and competence.
AREA Grant (R15)
The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the nation's research scientists, but that have not been major recipients of NIH support. AREA grants are intended to support small-scale health-related research projects proposed by faculty members of eligible domestic institutions.
The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Exploratory/Developmental Research Grant Program (R21)
The Exploratory/Developmental Grant (R21) program is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.
Early Career Research (ECR) Award (R21)
The NIDCD Early Career Reseach (ECR) Award (R21) replaced the NIDCD Small Grants (R03) program on December 11, 2015, and was reissued on December 11, 2017. The NIDCD Small Grant R03 program no longer exists, and new or resubmission applications for it will not be accepted.
While the purpose of the NIDCD ECR R21 Award is identical to the former R03 program, applicants should read the NIDCD ECR R21 Award announcement carefully because it contains some modifications, e.g., regarding Program Director/Principal Investigator effort. The NIDCD ECR R21 Award should not be considered a form of the NIH-wide parent R21 program listed above.
Individuals who had intended to prepare a resubmission application for the NIDCD Small Grant Program (R03) must instead submit a NEW application in response to the NIDCD Early Career Reseach (ECR) Award (R21) announcement, and must adhere to the guidance in Reminders Related to the NIH/AHRQ Policy for Application Submission. Individuals who are beyond the 7-year eligibility period must contact the NIDCD's Bracie Watson, Ph.D. to obtain written eligibility confirmation that must be included with the application.
Staff contact for questions on the NIDCD ECR R21 Award:
Bracie Watson, Ph.D.
National Institute on Deafness and Other Communication Disorders (NIDCD)